Date Filed | Type | Description |
06/07/2023 |
4
| Mauro David J (Chief Medical Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 190,713 shares
@ $0 Granted 381,426 options to buy
@ $8.77, valued at
$3.3M
|
|
06/07/2023 |
3
| Mauro David J (Chief Medical Officer) has filed a Form 3 on RECURSION PHARMACEUTICALS, INC. |
01/26/2023 |
4
| Mauro David J (Chief Medical Officer) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 190,000 options to buy
@ $0.74, valued at
$140.6k
|
|
09/20/2022 |
4
| Mauro David J (Chief Medical Officer) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
05/04/2022 |
4
| Mauro David J (Chief Medical Officer) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 200,000 options to buy
@ $3.26, valued at
$652k
Granted 20,000 restricted stock units
@ $0 |
|
05/04/2022 |
3
| Mauro David J (Chief Medical Officer) has filed a Form 3 on Codiak BioSciences, Inc. |
10/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/24/2020 |
3
| Mauro David J (Chief Medical Officer) has filed a Form 3 on Prelude Therapeutics Inc |